A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors

Hiroshi Fukamachi, Seon-Kyu Kim, Jiwon Koh, Hye Seung Lee, Yasushi Sasaki, Kentaro Yamashita, Taketo Nishikawaji, Shu Shimada, Yoshimitsu Akiyama, Sun-ju Byeon, Dong-Hyuck Bae, Keisuke Okuno, Masatoshi Nakagawa, Toshiro Tanioka, Mikito Inokuchi, Hiroshi Kawachi, Kiichiro Tsuchiya, Kazuyuki Kojima, Takashi Tokino, Yoshinobu Eishi, Yong Sung Kim, Woo Ho Kim, Yasuhito Yuasa, Shinji Tanaka

Open source

DOI
10.1186/s13046-019-1121-3
Published
2019-03-12
Container
Journal of Experimental & Clinical Cancer Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13046-019-1121-3,
  title = {A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors},
  author = {Hiroshi Fukamachi and Seon-Kyu Kim and Jiwon Koh and Hye Seung Lee and Yasushi Sasaki and Kentaro Yamashita and Taketo Nishikawaji and Shu Shimada and Yoshimitsu Akiyama and Sun-ju Byeon and Dong-Hyuck Bae and Keisuke Okuno and Masatoshi Nakagawa and Toshiro Tanioka and Mikito Inokuchi and Hiroshi Kawachi and Kiichiro Tsuchiya and Kazuyuki Kojima and Takashi Tokino and Yoshinobu Eishi and Yong Sung Kim and Woo Ho Kim and Yasuhito Yuasa and Shinji Tanaka},
  year = {2019},
  journal = {Journal of Experimental \& Clinical Cancer Research},
  doi = {10.1186/s13046-019-1121-3},
  url = {https://doi.org/10.1186/s13046-019-1121-3}
}

RIS

TY  - JOUR
TI  - A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors
AU  - Hiroshi Fukamachi
AU  - Seon-Kyu Kim
AU  - Jiwon Koh
AU  - Hye Seung Lee
AU  - Yasushi Sasaki
AU  - Kentaro Yamashita
AU  - Taketo Nishikawaji
AU  - Shu Shimada
AU  - Yoshimitsu Akiyama
AU  - Sun-ju Byeon
AU  - Dong-Hyuck Bae
AU  - Keisuke Okuno
AU  - Masatoshi Nakagawa
AU  - Toshiro Tanioka
AU  - Mikito Inokuchi
AU  - Hiroshi Kawachi
AU  - Kiichiro Tsuchiya
AU  - Kazuyuki Kojima
AU  - Takashi Tokino
AU  - Yoshinobu Eishi
AU  - Yong Sung Kim
AU  - Woo Ho Kim
AU  - Yasuhito Yuasa
AU  - Shinji Tanaka
PY  - 2019
JO  - Journal of Experimental & Clinical Cancer Research
DO  - 10.1186/s13046-019-1121-3
UR  - https://doi.org/10.1186/s13046-019-1121-3
ER  - 

APA

Fukamachi, H., Kim, S., Koh, J., Lee, H. S., Sasaki, Y., Yamashita, K., Nishikawaji, T., Shimada, S., Akiyama, Y., Byeon, S., Bae, D., Okuno, K., Nakagawa, M., Tanioka, T., Inokuchi, M., Kawachi, H., Tsuchiya, K., Kojima, K., Tokino, T., Eishi, Y., Kim, Y. S., Kim, W. H., Yuasa, Y., & Tanaka, S. (2019). A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-019-1121-3

Source records